Loading…

Chitooligosaccharide ameliorates diet-induced obesity in mice and affects adipose gene expression involved in adipogenesis and inflammation

Abstract Chitooligosaccharide (CO) has been reported to have potential antiobestic effects in a few studies, but the antiobesity properties of CO and its related mechanisms in models of dietary obesity remain unclear. We investigated the effect of CO on body weight gain, size of adipocytes, adipokin...

Full description

Saved in:
Bibliographic Details
Published in:Nutrition research (New York, N.Y.) N.Y.), 2012-03, Vol.32 (3), p.218-228
Main Authors: Choi, Eun Hye, Yang, Hyun Pil, Chun, Hyang Sook
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c446t-589c81d6e389e90a5df4c8390a766c009ed0838d3533a5255d1e26ba44fa13663
cites cdi_FETCH-LOGICAL-c446t-589c81d6e389e90a5df4c8390a766c009ed0838d3533a5255d1e26ba44fa13663
container_end_page 228
container_issue 3
container_start_page 218
container_title Nutrition research (New York, N.Y.)
container_volume 32
creator Choi, Eun Hye
Yang, Hyun Pil
Chun, Hyang Sook
description Abstract Chitooligosaccharide (CO) has been reported to have potential antiobestic effects in a few studies, but the antiobesity properties of CO and its related mechanisms in models of dietary obesity remain unclear. We investigated the effect of CO on body weight gain, size of adipocytes, adipokines, and lipid profiles in high-fat (HF) diet-induced obese mice and on the gene expression in adipose tissue using a complementary DNA microarray approach to test the hypothesis that CO supplementation would alleviate HF diet-induced obesity by the alteration of adipose tissue-specific gene expression. Male C57BL/6N mice were fed a normal diet (control), HF diet, or CO-supplemented HF diet (1% or 3%) for 5 months. Compared with the HF diet mice, mice fed the 3% CO-supplemented diet gained 15% less weight but did not display any change in food and energy intake. Chitooligosaccharide supplementation markedly improved serum and hepatic lipid profiles. Histologic examination showed that epididymal adipocyte size was smaller in mice fed the HF + 3% CO. Microarray analysis showed that dietary CO supplementation modulated adipogenesis-related genes such as matrix metallopeptidases 3 , 12 , 13 , and 14 ; tissue inhibitor of metalloproteinase 1 ; and cathepsin k in the adipose tissues. Twenty-five percent of the CO-responsive genes identified are involved in immune responses including the inflammatory response and cytokine production. These results suggest that CO supplementation may help ameliorate HF diet-induced weight gain and improve serum and liver lipid profile abnormalities, which are associated, at least in part, with altered adipose tissue gene expression involved in adipogenesis and inflammation.
doi_str_mv 10.1016/j.nutres.2012.02.004
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_963831084</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S0271531712000425</els_id><sourcerecordid>963831084</sourcerecordid><originalsourceid>FETCH-LOGICAL-c446t-589c81d6e389e90a5df4c8390a766c009ed0838d3533a5255d1e26ba44fa13663</originalsourceid><addsrcrecordid>eNqFksGO0zAQhiMEYsvCGyCUC-KUYseO41yQULWwSCtxAM6Wa092pyR28STV9hl4aZxtAYkL0kj24ftnRv8_RfGSszVnXL3drcM8JaB1zXi9ZrmYfFSsuG67irWie1ysWN3yqhG8vSieEe0Y4y0X4mlxUddSSc26VfFzc4dTjAPeRrLO3dmEHko7woAx2Qmo9AhThcHPDnwZt0A4HUsM5Ygug8GXtu_BTVRaj_tIUN5CgBLu93k3whgye4jDIYuz6IFZAEJ6EGPoBzuOdsrk8-JJbweCF-f3svj24err5rq6-fzx0-b9TeWkVFPV6M5p7hUI3UHHbON76bTIv1Ypx1gHnmmhvWiEsE3dNJ5DrbZWyt5yoZS4LN6c-u5T_DEDTWZEcjAMNkCcyXRKaMGZlpmUJ9KlSJSgN_uEo01Hw5lZUjA7c0rBLCkYlostslfnAfN2BP9H9Nv2DLw-A5acHfpkg0P6yzWtllLqzL07cZDtOCAkQw4h5CQwZc-Nj_i_Tf5t4AYMmGd-hyPQLs4pZKsNN5QF5styMcvB8Jpled2IX9gevz4</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>963831084</pqid></control><display><type>article</type><title>Chitooligosaccharide ameliorates diet-induced obesity in mice and affects adipose gene expression involved in adipogenesis and inflammation</title><source>ScienceDirect Freedom Collection 2022-2024</source><creator>Choi, Eun Hye ; Yang, Hyun Pil ; Chun, Hyang Sook</creator><creatorcontrib>Choi, Eun Hye ; Yang, Hyun Pil ; Chun, Hyang Sook</creatorcontrib><description>Abstract Chitooligosaccharide (CO) has been reported to have potential antiobestic effects in a few studies, but the antiobesity properties of CO and its related mechanisms in models of dietary obesity remain unclear. We investigated the effect of CO on body weight gain, size of adipocytes, adipokines, and lipid profiles in high-fat (HF) diet-induced obese mice and on the gene expression in adipose tissue using a complementary DNA microarray approach to test the hypothesis that CO supplementation would alleviate HF diet-induced obesity by the alteration of adipose tissue-specific gene expression. Male C57BL/6N mice were fed a normal diet (control), HF diet, or CO-supplemented HF diet (1% or 3%) for 5 months. Compared with the HF diet mice, mice fed the 3% CO-supplemented diet gained 15% less weight but did not display any change in food and energy intake. Chitooligosaccharide supplementation markedly improved serum and hepatic lipid profiles. Histologic examination showed that epididymal adipocyte size was smaller in mice fed the HF + 3% CO. Microarray analysis showed that dietary CO supplementation modulated adipogenesis-related genes such as matrix metallopeptidases 3 , 12 , 13 , and 14 ; tissue inhibitor of metalloproteinase 1 ; and cathepsin k in the adipose tissues. Twenty-five percent of the CO-responsive genes identified are involved in immune responses including the inflammatory response and cytokine production. These results suggest that CO supplementation may help ameliorate HF diet-induced weight gain and improve serum and liver lipid profile abnormalities, which are associated, at least in part, with altered adipose tissue gene expression involved in adipogenesis and inflammation.</description><identifier>ISSN: 0271-5317</identifier><identifier>EISSN: 1879-0739</identifier><identifier>DOI: 10.1016/j.nutres.2012.02.004</identifier><identifier>PMID: 22464809</identifier><identifier>CODEN: NTRSDC</identifier><language>eng</language><publisher>New York, NY: Elsevier Inc</publisher><subject>Adipocytes - drug effects ; Adipocytes - metabolism ; Adipocytes - pathology ; Adipogenesis ; Adipogenesis - drug effects ; Adipogenesis - genetics ; Animals ; Anti-Obesity Agents - pharmacology ; Anti-Obesity Agents - therapeutic use ; Biological and medical sciences ; Chitooligosaccharide ; Chitosan - pharmacology ; Chitosan - therapeutic use ; Cytokines - genetics ; Cytokines - metabolism ; Diet, High-Fat - adverse effects ; Dietary Fats - adverse effects ; Dietary Supplements ; Energy Intake - drug effects ; Feeding. Feeding behavior ; Fundamental and applied biological sciences. Psychology ; Gastroenterology and Hepatology ; Gene expression ; Gene Expression - drug effects ; High-fat diet ; Inflammation ; Inflammation - drug therapy ; Inflammation - genetics ; Inflammation - metabolism ; Lipid Metabolism - drug effects ; Lipid Metabolism - genetics ; Lipids - blood ; Liver - metabolism ; Male ; Mice ; Mice, Inbred C57BL ; Mice, Obese ; Microarray Analysis ; Obesity ; Obesity - drug therapy ; Obesity - genetics ; Obesity - metabolism ; Oligosaccharides - pharmacology ; Oligosaccharides - therapeutic use ; Vertebrates: anatomy and physiology, studies on body, several organs or systems ; Weight Gain - drug effects ; Weight Gain - genetics</subject><ispartof>Nutrition research (New York, N.Y.), 2012-03, Vol.32 (3), p.218-228</ispartof><rights>Elsevier Inc.</rights><rights>2012 Elsevier Inc.</rights><rights>2015 INIST-CNRS</rights><rights>Copyright © 2012 Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c446t-589c81d6e389e90a5df4c8390a766c009ed0838d3533a5255d1e26ba44fa13663</citedby><cites>FETCH-LOGICAL-c446t-589c81d6e389e90a5df4c8390a766c009ed0838d3533a5255d1e26ba44fa13663</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>315,786,790,27957,27958</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=25784448$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22464809$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Choi, Eun Hye</creatorcontrib><creatorcontrib>Yang, Hyun Pil</creatorcontrib><creatorcontrib>Chun, Hyang Sook</creatorcontrib><title>Chitooligosaccharide ameliorates diet-induced obesity in mice and affects adipose gene expression involved in adipogenesis and inflammation</title><title>Nutrition research (New York, N.Y.)</title><addtitle>Nutr Res</addtitle><description>Abstract Chitooligosaccharide (CO) has been reported to have potential antiobestic effects in a few studies, but the antiobesity properties of CO and its related mechanisms in models of dietary obesity remain unclear. We investigated the effect of CO on body weight gain, size of adipocytes, adipokines, and lipid profiles in high-fat (HF) diet-induced obese mice and on the gene expression in adipose tissue using a complementary DNA microarray approach to test the hypothesis that CO supplementation would alleviate HF diet-induced obesity by the alteration of adipose tissue-specific gene expression. Male C57BL/6N mice were fed a normal diet (control), HF diet, or CO-supplemented HF diet (1% or 3%) for 5 months. Compared with the HF diet mice, mice fed the 3% CO-supplemented diet gained 15% less weight but did not display any change in food and energy intake. Chitooligosaccharide supplementation markedly improved serum and hepatic lipid profiles. Histologic examination showed that epididymal adipocyte size was smaller in mice fed the HF + 3% CO. Microarray analysis showed that dietary CO supplementation modulated adipogenesis-related genes such as matrix metallopeptidases 3 , 12 , 13 , and 14 ; tissue inhibitor of metalloproteinase 1 ; and cathepsin k in the adipose tissues. Twenty-five percent of the CO-responsive genes identified are involved in immune responses including the inflammatory response and cytokine production. These results suggest that CO supplementation may help ameliorate HF diet-induced weight gain and improve serum and liver lipid profile abnormalities, which are associated, at least in part, with altered adipose tissue gene expression involved in adipogenesis and inflammation.</description><subject>Adipocytes - drug effects</subject><subject>Adipocytes - metabolism</subject><subject>Adipocytes - pathology</subject><subject>Adipogenesis</subject><subject>Adipogenesis - drug effects</subject><subject>Adipogenesis - genetics</subject><subject>Animals</subject><subject>Anti-Obesity Agents - pharmacology</subject><subject>Anti-Obesity Agents - therapeutic use</subject><subject>Biological and medical sciences</subject><subject>Chitooligosaccharide</subject><subject>Chitosan - pharmacology</subject><subject>Chitosan - therapeutic use</subject><subject>Cytokines - genetics</subject><subject>Cytokines - metabolism</subject><subject>Diet, High-Fat - adverse effects</subject><subject>Dietary Fats - adverse effects</subject><subject>Dietary Supplements</subject><subject>Energy Intake - drug effects</subject><subject>Feeding. Feeding behavior</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Gastroenterology and Hepatology</subject><subject>Gene expression</subject><subject>Gene Expression - drug effects</subject><subject>High-fat diet</subject><subject>Inflammation</subject><subject>Inflammation - drug therapy</subject><subject>Inflammation - genetics</subject><subject>Inflammation - metabolism</subject><subject>Lipid Metabolism - drug effects</subject><subject>Lipid Metabolism - genetics</subject><subject>Lipids - blood</subject><subject>Liver - metabolism</subject><subject>Male</subject><subject>Mice</subject><subject>Mice, Inbred C57BL</subject><subject>Mice, Obese</subject><subject>Microarray Analysis</subject><subject>Obesity</subject><subject>Obesity - drug therapy</subject><subject>Obesity - genetics</subject><subject>Obesity - metabolism</subject><subject>Oligosaccharides - pharmacology</subject><subject>Oligosaccharides - therapeutic use</subject><subject>Vertebrates: anatomy and physiology, studies on body, several organs or systems</subject><subject>Weight Gain - drug effects</subject><subject>Weight Gain - genetics</subject><issn>0271-5317</issn><issn>1879-0739</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><recordid>eNqFksGO0zAQhiMEYsvCGyCUC-KUYseO41yQULWwSCtxAM6Wa092pyR28STV9hl4aZxtAYkL0kj24ftnRv8_RfGSszVnXL3drcM8JaB1zXi9ZrmYfFSsuG67irWie1ysWN3yqhG8vSieEe0Y4y0X4mlxUddSSc26VfFzc4dTjAPeRrLO3dmEHko7woAx2Qmo9AhThcHPDnwZt0A4HUsM5Ygug8GXtu_BTVRaj_tIUN5CgBLu93k3whgye4jDIYuz6IFZAEJ6EGPoBzuOdsrk8-JJbweCF-f3svj24err5rq6-fzx0-b9TeWkVFPV6M5p7hUI3UHHbON76bTIv1Ypx1gHnmmhvWiEsE3dNJ5DrbZWyt5yoZS4LN6c-u5T_DEDTWZEcjAMNkCcyXRKaMGZlpmUJ9KlSJSgN_uEo01Hw5lZUjA7c0rBLCkYlostslfnAfN2BP9H9Nv2DLw-A5acHfpkg0P6yzWtllLqzL07cZDtOCAkQw4h5CQwZc-Nj_i_Tf5t4AYMmGd-hyPQLs4pZKsNN5QF5styMcvB8Jpled2IX9gevz4</recordid><startdate>20120301</startdate><enddate>20120301</enddate><creator>Choi, Eun Hye</creator><creator>Yang, Hyun Pil</creator><creator>Chun, Hyang Sook</creator><general>Elsevier Inc</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20120301</creationdate><title>Chitooligosaccharide ameliorates diet-induced obesity in mice and affects adipose gene expression involved in adipogenesis and inflammation</title><author>Choi, Eun Hye ; Yang, Hyun Pil ; Chun, Hyang Sook</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c446t-589c81d6e389e90a5df4c8390a766c009ed0838d3533a5255d1e26ba44fa13663</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Adipocytes - drug effects</topic><topic>Adipocytes - metabolism</topic><topic>Adipocytes - pathology</topic><topic>Adipogenesis</topic><topic>Adipogenesis - drug effects</topic><topic>Adipogenesis - genetics</topic><topic>Animals</topic><topic>Anti-Obesity Agents - pharmacology</topic><topic>Anti-Obesity Agents - therapeutic use</topic><topic>Biological and medical sciences</topic><topic>Chitooligosaccharide</topic><topic>Chitosan - pharmacology</topic><topic>Chitosan - therapeutic use</topic><topic>Cytokines - genetics</topic><topic>Cytokines - metabolism</topic><topic>Diet, High-Fat - adverse effects</topic><topic>Dietary Fats - adverse effects</topic><topic>Dietary Supplements</topic><topic>Energy Intake - drug effects</topic><topic>Feeding. Feeding behavior</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Gastroenterology and Hepatology</topic><topic>Gene expression</topic><topic>Gene Expression - drug effects</topic><topic>High-fat diet</topic><topic>Inflammation</topic><topic>Inflammation - drug therapy</topic><topic>Inflammation - genetics</topic><topic>Inflammation - metabolism</topic><topic>Lipid Metabolism - drug effects</topic><topic>Lipid Metabolism - genetics</topic><topic>Lipids - blood</topic><topic>Liver - metabolism</topic><topic>Male</topic><topic>Mice</topic><topic>Mice, Inbred C57BL</topic><topic>Mice, Obese</topic><topic>Microarray Analysis</topic><topic>Obesity</topic><topic>Obesity - drug therapy</topic><topic>Obesity - genetics</topic><topic>Obesity - metabolism</topic><topic>Oligosaccharides - pharmacology</topic><topic>Oligosaccharides - therapeutic use</topic><topic>Vertebrates: anatomy and physiology, studies on body, several organs or systems</topic><topic>Weight Gain - drug effects</topic><topic>Weight Gain - genetics</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Choi, Eun Hye</creatorcontrib><creatorcontrib>Yang, Hyun Pil</creatorcontrib><creatorcontrib>Chun, Hyang Sook</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Nutrition research (New York, N.Y.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Choi, Eun Hye</au><au>Yang, Hyun Pil</au><au>Chun, Hyang Sook</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Chitooligosaccharide ameliorates diet-induced obesity in mice and affects adipose gene expression involved in adipogenesis and inflammation</atitle><jtitle>Nutrition research (New York, N.Y.)</jtitle><addtitle>Nutr Res</addtitle><date>2012-03-01</date><risdate>2012</risdate><volume>32</volume><issue>3</issue><spage>218</spage><epage>228</epage><pages>218-228</pages><issn>0271-5317</issn><eissn>1879-0739</eissn><coden>NTRSDC</coden><notes>ObjectType-Article-1</notes><notes>SourceType-Scholarly Journals-1</notes><notes>ObjectType-Feature-2</notes><notes>content type line 23</notes><abstract>Abstract Chitooligosaccharide (CO) has been reported to have potential antiobestic effects in a few studies, but the antiobesity properties of CO and its related mechanisms in models of dietary obesity remain unclear. We investigated the effect of CO on body weight gain, size of adipocytes, adipokines, and lipid profiles in high-fat (HF) diet-induced obese mice and on the gene expression in adipose tissue using a complementary DNA microarray approach to test the hypothesis that CO supplementation would alleviate HF diet-induced obesity by the alteration of adipose tissue-specific gene expression. Male C57BL/6N mice were fed a normal diet (control), HF diet, or CO-supplemented HF diet (1% or 3%) for 5 months. Compared with the HF diet mice, mice fed the 3% CO-supplemented diet gained 15% less weight but did not display any change in food and energy intake. Chitooligosaccharide supplementation markedly improved serum and hepatic lipid profiles. Histologic examination showed that epididymal adipocyte size was smaller in mice fed the HF + 3% CO. Microarray analysis showed that dietary CO supplementation modulated adipogenesis-related genes such as matrix metallopeptidases 3 , 12 , 13 , and 14 ; tissue inhibitor of metalloproteinase 1 ; and cathepsin k in the adipose tissues. Twenty-five percent of the CO-responsive genes identified are involved in immune responses including the inflammatory response and cytokine production. These results suggest that CO supplementation may help ameliorate HF diet-induced weight gain and improve serum and liver lipid profile abnormalities, which are associated, at least in part, with altered adipose tissue gene expression involved in adipogenesis and inflammation.</abstract><cop>New York, NY</cop><pub>Elsevier Inc</pub><pmid>22464809</pmid><doi>10.1016/j.nutres.2012.02.004</doi><tpages>11</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0271-5317
ispartof Nutrition research (New York, N.Y.), 2012-03, Vol.32 (3), p.218-228
issn 0271-5317
1879-0739
language eng
recordid cdi_proquest_miscellaneous_963831084
source ScienceDirect Freedom Collection 2022-2024
subjects Adipocytes - drug effects
Adipocytes - metabolism
Adipocytes - pathology
Adipogenesis
Adipogenesis - drug effects
Adipogenesis - genetics
Animals
Anti-Obesity Agents - pharmacology
Anti-Obesity Agents - therapeutic use
Biological and medical sciences
Chitooligosaccharide
Chitosan - pharmacology
Chitosan - therapeutic use
Cytokines - genetics
Cytokines - metabolism
Diet, High-Fat - adverse effects
Dietary Fats - adverse effects
Dietary Supplements
Energy Intake - drug effects
Feeding. Feeding behavior
Fundamental and applied biological sciences. Psychology
Gastroenterology and Hepatology
Gene expression
Gene Expression - drug effects
High-fat diet
Inflammation
Inflammation - drug therapy
Inflammation - genetics
Inflammation - metabolism
Lipid Metabolism - drug effects
Lipid Metabolism - genetics
Lipids - blood
Liver - metabolism
Male
Mice
Mice, Inbred C57BL
Mice, Obese
Microarray Analysis
Obesity
Obesity - drug therapy
Obesity - genetics
Obesity - metabolism
Oligosaccharides - pharmacology
Oligosaccharides - therapeutic use
Vertebrates: anatomy and physiology, studies on body, several organs or systems
Weight Gain - drug effects
Weight Gain - genetics
title Chitooligosaccharide ameliorates diet-induced obesity in mice and affects adipose gene expression involved in adipogenesis and inflammation
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-09-22T18%3A17%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Chitooligosaccharide%20ameliorates%20diet-induced%20obesity%20in%20mice%20and%20affects%20adipose%20gene%20expression%20involved%20in%20adipogenesis%20and%20inflammation&rft.jtitle=Nutrition%20research%20(New%20York,%20N.Y.)&rft.au=Choi,%20Eun%20Hye&rft.date=2012-03-01&rft.volume=32&rft.issue=3&rft.spage=218&rft.epage=228&rft.pages=218-228&rft.issn=0271-5317&rft.eissn=1879-0739&rft.coden=NTRSDC&rft_id=info:doi/10.1016/j.nutres.2012.02.004&rft_dat=%3Cproquest_cross%3E963831084%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c446t-589c81d6e389e90a5df4c8390a766c009ed0838d3533a5255d1e26ba44fa13663%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=963831084&rft_id=info:pmid/22464809&rfr_iscdi=true